ObsEva SA
Related Filers (18)
- Loumaye Ernest (11)
- Sofinnova Venture Partners VIII, L.P. (6)
- Venrock Healthcare Capital Partners II, L.P. (3)
- HBM Healthcare Investments (Cayman) Ltd. (3)
- Sofinnova Capital VII FCPR (3)
- Medicxi Growth I LP (3)
- ORBIMED ADVISORS LLC (3)
- Ares Trading S.A. (2)
- ARMISTICE CAPITAL, LLC (2)
- Brown William Michael (2)
- Novo Holdings A/S (1)
- New Enterprise Associates 15, L.P. (1)
- VANLENT ANNE (1)
- Brown Stephanie Clare (1)
- Clancy Annette (1)
- Mathers Edward T (1)
- Edfjall Catarina (1)
- O'CALLAGHAN BRIAN (1)
- Show More ...
News (7)
8-K
Tuesday, 4/11/2023
Current report filing
8-K
Wednesday, 3/22/2023
Current report filing
8-K
Wednesday, 3/15/2023
Current report filing
8-K
Monday, 3/13/2023
Current report filing
8-K
Wednesday, 3/1/2023
Current report filing
8-K
Friday, 2/24/2023
Current report filing
8-K
Tuesday, 1/3/2023
Current report filing
Other (183)
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
EFFECT
Wednesday, 3/29/2023
Notice of Effectiveness
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
POS AM
Tuesday, 3/28/2023
Post-effective amendment to a registration statement that is not immediately effective upon filing
25
Monday, 3/27/2023
Notification filed by issuer to voluntarily withdraw a class of securities from listing and registration on a national securities exchange
6-K
Monday, 12/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 12/14/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 12/12/2022
Notice of Effectiveness
CORRESP
Friday, 12/9/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
6-K
Friday, 12/9/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3
Friday, 12/9/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 12/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/26/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 10/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Tuesday, 9/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/13/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 8/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 8/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
F-3MEF
Wednesday, 8/3/2022
A new registration statement filed under Rule 462(b) to add securities to a prior related effective registration statement filed on Form F 3
6-K
Monday, 8/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 7/29/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 6/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 5/27/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/19/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/17/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 5/2/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 4/25/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/7/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 3/31/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 3/22/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Thursday, 3/10/2022
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Thursday, 3/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Tuesday, 3/1/2022
Notice of Effectiveness
EFFECT
Tuesday, 3/1/2022
Notice of Effectiveness
CORRESP
Friday, 2/25/2022
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3/A
Friday, 2/25/2022
Registration statement for specified transactions by certain foreign private issuers
F-3
Thursday, 2/17/2022
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 2/10/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 2/4/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 2/1/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 1/28/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/6/2022
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/17/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 12/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 12/10/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
EFFECT
Monday, 11/22/2021
Notice of Effectiveness
CORRESP
Friday, 11/19/2021
A correspondence can be sent as a document with another submission type or can be sent as a separate submission.
F-3
Wednesday, 11/10/2021
Registration statement for specified transactions by certain foreign private issuers
6-K
Thursday, 11/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 10/29/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Wednesday, 10/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 10/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/27/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/1/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 5/25/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/20/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/6/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 5/6/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 4/22/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 3/31/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 3/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
20-F
Friday, 3/5/2021
Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)
6-K
Friday, 3/5/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/17/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 2/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 2/10/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 1/28/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Tuesday, 1/19/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 1/13/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/11/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K/A
Monday, 1/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 1/4/2021
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 12/10/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 11/24/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/16/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 11/9/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 11/5/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 9/8/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Friday, 8/14/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 8/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 7/7/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Monday, 7/6/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Wednesday, 7/1/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Tuesday, 6/9/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
6-K
Thursday, 6/4/2020
Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments
Ownership (46)
SC 13D
Monday, 4/17/2023
Loumaye Ernest: Major Shareholders
4
Tuesday, 4/11/2023
Loumaye Ernest: Statement of changes in beneficial ownership of securities
4
Thursday, 3/2/2023
Loumaye Ernest: Statement of changes in beneficial ownership of securities
4
Friday, 2/24/2023
Brown William Michael: Statement of changes in beneficial ownership of securities
3/A
Tuesday, 2/14/2023
Loumaye Ernest: Initial statement of beneficial ownership of securities
SC 13G/A
Tuesday, 2/14/2023
Loumaye Ernest: Major Shareholders
SC 13D/A
Monday, 2/6/2023
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
3
Tuesday, 1/3/2023
Brown William Michael: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
Brown Stephanie Clare: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
Mathers Edward T: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
Edfjall Catarina: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
VANLENT ANNE: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
Loumaye Ernest: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
Clancy Annette: Initial statement of beneficial ownership of securities
3
Tuesday, 1/3/2023
O'CALLAGHAN BRIAN: Initial statement of beneficial ownership of securities
SC 13D/A
Monday, 2/28/2022
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
SC 13G/A
Monday, 2/14/2022
Loumaye Ernest: Major Shareholders
SC 13D/A
Thursday, 3/4/2021
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G/A
Tuesday, 2/16/2021
Loumaye Ernest: Major Shareholders
SC 13G/A
Friday, 2/12/2021
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G/A
Thursday, 2/11/2021
Medicxi Growth I LP: Major Shareholders
SC 13G
Monday, 9/14/2020
ARMISTICE CAPITAL, LLC: Major Shareholders
SC 13G/A
Friday, 2/14/2020
Venrock Healthcare Capital Partners II, L.P.: Major Shareholders
SC 13G/A
Friday, 2/14/2020
Loumaye Ernest: Major Shareholders
SC 13D/A
Thursday, 2/13/2020
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
Sofinnova Capital VII FCPR: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
Venrock Healthcare Capital Partners II, L.P.: Major Shareholders
SC 13G/A
Thursday, 2/14/2019
HBM Healthcare Investments (Cayman) Ltd.: Major Shareholders
SC 13G/A
Tuesday, 2/12/2019
Loumaye Ernest: Major Shareholders
SC 13G/A
Friday, 10/5/2018
Sofinnova Capital VII FCPR: Major Shareholders
SC 13G/A
Wednesday, 2/14/2018
Medicxi Growth I LP: Major Shareholders
SC 13G
Wednesday, 2/14/2018
Loumaye Ernest: Major Shareholders
SC 13G/A
Wednesday, 2/14/2018
HBM Healthcare Investments (Cayman) Ltd.: Major Shareholders
SC 13G
Wednesday, 2/14/2018
Sofinnova Capital VII FCPR: Major Shareholders
SC 13G/A
Tuesday, 2/13/2018
ORBIMED ADVISORS LLC: Major Shareholders
SC 13G
Thursday, 2/1/2018
Venrock Healthcare Capital Partners II, L.P.: Major Shareholders
SC 13G/A
Monday, 1/22/2018
Ares Trading S.A.: Major Shareholders
SC 13G
Thursday, 10/26/2017
Ares Trading S.A.: Major Shareholders
SC 13D/A
Thursday, 10/19/2017
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
SC 13D
Tuesday, 10/17/2017
New Enterprise Associates 15, L.P.: Major Shareholders
SC 13G
Thursday, 8/31/2017
Medicxi Growth I LP: Major Shareholders
SC 13G
Friday, 7/28/2017
Novo Holdings A/S: Major Shareholders
SC 13G
Monday, 3/13/2017
HBM Healthcare Investments (Cayman) Ltd.: Major Shareholders
SC 13D
Monday, 2/6/2017
Sofinnova Venture Partners VIII, L.P.: Major Shareholders
SC 13G
Friday, 2/3/2017
ORBIMED ADVISORS LLC: Major Shareholders
Prospectus (25)
S-8 POS
Tuesday, 3/28/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/28/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/28/2023
Post-effective amendment to a S-8 registration statement
S-8 POS
Tuesday, 3/28/2023
Post-effective amendment to a S-8 registration statement
424B7
Thursday, 3/3/2022
Prospectus filed pursuant to Rule 424(b)(7)
S-8
Wednesday, 3/2/2022
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B7
Tuesday, 11/23/2021
Prospectus filed pursuant to Rule 424(b)(7)
424B5
Friday, 3/5/2021
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 10/13/2020
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Tuesday, 9/8/2020
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Wednesday, 8/7/2019
Prospectus filed pursuant to Rule 424(b)(5)
S-8
Tuesday, 5/21/2019
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B5
Wednesday, 6/20/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Tuesday, 6/19/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B5
Monday, 3/19/2018
Prospectus filed pursuant to Rule 424(b)(5)
424B3
Monday, 2/26/2018
Prospectus filed pursuant to Rule 424(b)(3)
424B4
Monday, 11/20/2017
Prospectus filed pursuant to Rule 424(b)(4)
424B3
Monday, 11/20/2017
Prospectus filed pursuant to Rule 424(b)(3)
S-8
Wednesday, 2/22/2017
Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
424B4
Friday, 1/27/2017
Prospectus filed pursuant to Rule 424(b)(4)
DRS/A
Wednesday, 12/28/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRSLTR
Tuesday, 12/27/2016
Correspondence Related to Draft Registration Statement
DRSLTR
Monday, 12/5/2016
Correspondence Related to Draft Registration Statement
DRS/A
Monday, 12/5/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
DRS
Friday, 10/14/2016
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy